Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 14851-14900 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT06248528
Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.
NA
Active, not recruiting
1,076 participants
Started: Dec 1, 2019 · Completed: Jan 31, 2027
1 condition
1 sponsor
1 location
NCT02234219
Comparison of Circular(Soave) and Heart-shaped Anastomosis in Hirschsprung's Disease
NA
Active, not recruiting
177 participants
Started: Nov 30, 2019 · Completed: Oct 30, 2025
1 condition
1 sponsor
1 location
NCT04122248
M6-C Post Approval Study (PAS)
N/A
Active, not recruiting
152 participants
Started: Nov 30, 2019 · Completed: Jun 30, 2026
4 conditions
1 sponsor
21 locations
NCT03899987
Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery
PHASE2
Active, not recruiting
12 participants
Started: Nov 29, 2019 · Completed: Nov 29, 2026
10 conditions
2 sponsors
1 location
NCT04128904
In Vitro Fertilisation Versus Intracytoplasmic Sperm Injection in Patients Without Severe Male Factor Infertility
NA
Active, not recruiting
824 participants
Started: Nov 29, 2019 · Completed: Dec 14, 2027
1 condition
1 sponsor
6 locations
NCT03849131
Patient-Reported AutoImmunity Secondary to Cancer immunothErapy
PHASE4
Active, not recruiting
905 participants
Started: Nov 29, 2019 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT04085250
Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy
PHASE2
Active, not recruiting
264 participants
Started: Nov 28, 2019 · Completed: Jan 31, 2025
1 condition
1 sponsor
3 locations
NCT04179032
Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)
PHASE2
Active, not recruiting
25 participants
Started: Nov 28, 2019 · Completed: Apr 26, 2027
1 condition
1 sponsor
11 locations
NCT04069533
Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A
PHASE2
Active, not recruiting
7 participants
Started: Nov 28, 2019 · Completed: Feb 28, 2025
1 condition
1 sponsor
2 locations
NCT04060277
Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation
PHASE2
Active, not recruiting
7 participants
Started: Nov 27, 2019 · Completed: Apr 7, 2030
12 conditions
2 sponsors
1 location
NCT04164966
Development of Novel Biomarkers for the Early Diagnosis of Type 1 Diabetes
N/A
Active, not recruiting
28 participants
Started: Nov 27, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04106908
Effectiveness and Tolerability of Eqwilate in Real-life Conditions
N/A
Active, not recruiting
38 participants
Started: Nov 27, 2019 · Completed: Nov 30, 2026
1 condition
1 sponsor
9 locations
NCT04026295
Short-Burst Interval Treadmill Training Cerebral Palsy
NA
Active, not recruiting
60 participants
Started: Nov 27, 2019 · Completed: Aug 31, 2025
1 condition
3 sponsors
2 locations
NCT05741723
OCS DCD Heart + CAP Continued Follow-Up
N/A
Active, not recruiting
276 participants
Started: Nov 26, 2019 · Completed: Oct 31, 2026
1 condition
1 sponsor
20 locations
NCT04180579
Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients
NA
Active, not recruiting
34 participants
Started: Nov 26, 2019 · Completed: May 31, 2026
4 conditions
1 sponsor
1 location
NCT04153149
HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
PHASE3
Active, not recruiting
655 participants
Started: Nov 26, 2019 · Completed: Dec 1, 2026
1 condition
1 sponsor
79 locations
NCT07217119
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Feladilimab (GSK3359609) in Participants With RRMM
PHASE1/PHASE2
Active, not recruiting
25 participants
Started: Nov 26, 2019 · Completed: Mar 11, 2027
1 condition
1 sponsor
11 locations
NCT04204655
Influence of the Body Composition of Neurological (Early) Rehabilitants on Rehabilitation Success
N/A
Active, not recruiting
57 participants
Started: Nov 25, 2019 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT04186546
Zephyr Valve Registry (ZEVR)
N/A
Active, not recruiting
150 participants
Started: Nov 25, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
11 locations
NCT04193579
Listening to Mom 2: Neural, Clinical and Language Outcomes
NA
Active, not recruiting
57 participants
Started: Nov 25, 2019 · Completed: Mar 1, 2026
1 condition
2 sponsors
1 location
NCT03877029
Long-term Effects of Breast Cancer Treatment
N/A
Active, not recruiting
4,487 participants
Started: Nov 23, 2019 · Completed: May 31, 2025
1 condition
2 sponsors
1 location
NCT04049825
A Phase 1 Trial of OPB-111077 in Combination With Bendamustine and Rituximab in Patients With r/r DLBCL
PHASE1
Active, not recruiting
36 participants
Started: Nov 22, 2019 · Completed: Mar 31, 2025
1 condition
1 sponsor
1 location
NCT04203576
First in Human Clinical Investigation of the FIRE1 System in Heart Failure Patients (FUTURE-HF)
NA
Active, not recruiting
50 participants
Started: Nov 22, 2019 · Completed: Sep 30, 2029
1 condition
1 sponsor
13 locations
NCT04151667
Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma
PHASE2
Active, not recruiting
33 participants
Started: Nov 22, 2019 · Completed: May 31, 2026
1 condition
2 sponsors
1 location
NCT06546306
Post Market Clinical Follow-Up TOUCH® CMC 1
N/A
Active, not recruiting
216 participants
Started: Nov 22, 2019 · Completed: Dec 31, 2031
1 condition
1 sponsor
6 locations
NCT04009330
Clinical Evaluation of a Point of Care (POC) Assay to Identify Phenotypes in the Acute Respiratory Distress Syndrome
N/A
Active, not recruiting
480 participants
Started: Nov 22, 2019 · Completed: Feb 27, 2026
1 condition
3 sponsors
22 locations
NCT04179162
Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment
PHASE1/PHASE2
Active, not recruiting
54 participants
Started: Nov 22, 2019 · Completed: Nov 30, 2026
1 condition
1 sponsor
8 locations
NCT04013685
Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
PHASE1
Active, not recruiting
255 participants
Started: Nov 21, 2019 · Completed: Apr 30, 2027
6 conditions
1 sponsor
21 locations
NCT03842228
Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected Mutations
PHASE1
Active, not recruiting
39 participants
Started: Nov 21, 2019 · Completed: Sep 24, 2026
3 conditions
1 sponsor
17 locations
NCT04150068
Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance
PHASE2/PHASE3
Active, not recruiting
72 participants
Started: Nov 21, 2019 · Completed: Jan 31, 2027
1 condition
1 sponsor
75 locations
NCT04175210
Prospective Randomized Study of Accelerated Radiation Therapy (PRART)
PHASE3
Active, not recruiting
400 participants
Started: Nov 21, 2019 · Completed: Jun 30, 2030
1 condition
1 sponsor
3 locations
NCT04179643
AB-1002 in Patients With Class III Heart Failure
PHASE1
Active, not recruiting
17 participants
Started: Nov 20, 2019 · Completed: Sep 30, 2026
9 conditions
1 sponsor
4 locations
NCT04187651
PRP Use in Treatment of Fistula Ano
NA
Active, not recruiting
100 participants
Started: Nov 20, 2019 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT04083976
A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations
PHASE2
Active, not recruiting
316 participants
Started: Nov 20, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
171 locations
NCT04114825
Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer
PHASE2
Active, not recruiting
180 participants
Started: Nov 19, 2019 · Completed: Nov 30, 2022
1 condition
1 sponsor
36 locations
NCT04019002
Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma
PHASE1
Active, not recruiting
17 participants
Started: Nov 19, 2019 · Completed: Sep 30, 2025
1 condition
2 sponsors
1 location
NCT04114981
Single Fraction Stereotactic Radiosurgery Compared with Fractionated Stereotactic Radiosurgery in Treating Patients with Resected Metastatic Brain Disease
PHASE3
Active, not recruiting
242 participants
Started: Nov 19, 2019 · Completed: Mar 31, 2028
1 condition
2 sponsors
232 locations
NCT03610971
Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors
PHASE2
Active, not recruiting
24 participants
Started: Nov 19, 2019 · Completed: Feb 28, 2026
2 conditions
3 sponsors
8 locations
NCT04174196
A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma
PHASE2
Active, not recruiting
21 participants
Started: Nov 19, 2019 · Completed: Nov 19, 2025
3 conditions
1 sponsor
7 locations
NCT03944798
Surveillance AFter Extremity Tumor surgerY
NA
Active, not recruiting
310 participants
Started: Nov 19, 2019 · Completed: Dec 31, 2027
2 conditions
6 sponsors
35 locations
NCT04123366
Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)
PHASE2
Active, not recruiting
300 participants
Started: Nov 18, 2019 · Completed: Jul 23, 2026
1 condition
1 sponsor
135 locations
NCT04122235
The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study
NA
Active, not recruiting
754 participants
Started: Nov 18, 2019 · Completed: Dec 31, 2030
6 conditions
3 sponsors
12 locations
NCT03854474
Testing the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced Urothelial Carcinoma
PHASE1/PHASE2
Active, not recruiting
30 participants
Started: Nov 18, 2019 · Completed: Jun 30, 2026
4 conditions
1 sponsor
34 locations
NCT03928236
Benzodiazepine-free Cardiac Anesthesia for Reduction of Postoperative Delirium
NA
Active, not recruiting
15,886 participants
Started: Nov 18, 2019 · Completed: Apr 30, 2025
2 conditions
1 sponsor
20 locations
NCT04130997
An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis
PHASE3
Active, not recruiting
1,100 participants
Started: Nov 18, 2019 · Completed: Feb 1, 2030
1 condition
1 sponsor
86 locations
NCT04201184
Wakȟáŋyeža (Little Holy One)
NA
Active, not recruiting
124 participants
Started: Nov 18, 2019 · Completed: Jan 31, 2026
3 conditions
3 sponsors
1 location
NCT04105530
Transcranial Direct Current Stimulation of the Temporal Cortex in Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)
NA
Active, not recruiting
36 participants
Started: Nov 18, 2019 · Completed: Sep 30, 2024
3 conditions
1 sponsor
1 location
NCT03844815
Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia
PHASE1
Active, not recruiting
26 participants
Started: Nov 18, 2019 · Completed: Dec 10, 2025
1 condition
2 sponsors
1 location
NCT05119166
International Milk Composition (IMiC) Consortium
N/A
Active, not recruiting
1,000 participants
Started: Nov 17, 2019 · Completed: Oct 30, 2025
3 conditions
19 sponsors
1 location
NCT05989191
Study for the Reliability and Validity of the EORTC PATSAT-C33 and the EORTC OUT-PATSAT7 Questionnaires
N/A
Active, not recruiting
690 participants
Started: Nov 15, 2019 · Completed: Mar 30, 2025
1 condition
1 sponsor
2 locations
Previous
1
More pages
295
296
297
298
299
300
301
More pages
431
Next